Foley Partner Stephen Maebius was quoted in an article that appeared in BioWorld Today on September 12, 2011 titled “Passage of Patent Reform Bill is Just the Beginning.” Maebius discusses the America Invents Act, a major patent reform bill which he identifies as a wide scope of change that is likely to develop for several years as the courts interpret the Act in future patent lawsuits. Regarding biotech, he views the Act’s extension of the prior use defense as a potential benefit to a company that is developing a product but is not the first to file. Maebius adds that the Supreme Court will still need to resolve issues such as patent eligibility, which were not addressed by the reform.
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.